[Screening for colon cancer].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 7555806)

Published in Duodecim on January 01, 1994

Authors

H J Järvinen1, J P Mecklin

Author Affiliations

1: HYKS:n II kirurgian klinikka, Helsinki.

Articles by these authors

Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology (1999) 11.94

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum (1991) 9.82

Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med (1998) 8.47

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (2000) 8.41

Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73

Genetic mapping of a locus predisposing to human colorectal cancer. Science (1993) 4.12

Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol (2000) 3.98

Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (1995) 3.45

Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res (1994) 3.25

Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology (2000) 3.01

Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer (1995) 2.85

Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology (1996) 2.60

Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med (1995) 2.40

Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res (2001) 2.12

Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet (1994) 2.08

The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol (2001) 1.84

Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81

Clinical features of colorectal carcinoma in cancer family syndrome. Dis Colon Rectum (1986) 1.79

DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet (1996) 1.64

Genetic reconstruction of individual colorectal tumor histories. Proc Natl Acad Sci U S A (2000) 1.63

Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasms. Scand J Gastroenterol (2003) 1.57

Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer (1984) 1.56

Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer (2000) 1.49

Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer (1998) 1.48

Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer. Am J Pathol (1999) 1.38

A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev (1994) 1.36

Follow-up of patients operated on for colorectal carcinoma. Am J Surg (1990) 1.33

Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion (2000) 1.27

Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma. Clin Cancer Res (2001) 1.24

Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer (2001) 1.23

Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families. Proc Natl Acad Sci U S A (1994) 1.14

Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect Prev (2000) 1.12

Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations. Fam Cancer (2001) 1.11

No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in left-sided colorectal carcinomas. Cancer Res (2000) 1.11

Histopathology of colorectal carcinomas and adenomas in cancer family syndrome. Dis Colon Rectum (1986) 1.11

SMAD genes in juvenile polyposis. Genes Chromosomes Cancer (1999) 1.10

The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med (1994) 1.10

Cancer family syndrome. Genetic analysis of 22 Finnish kindreds. Gastroenterology (1986) 1.09

MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. Cancer Res (2001) 1.06

Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer (1997) 1.06

Complete and incomplete intestinal metaplasia at the oesophagogastric junction: prevalences and associations with endoscopic erosive oesophagitis and gastritis. Gut (1999) 1.04

Diploid predominance in hereditary nonpolyposis colorectal carcinoma evaluated by flow cytometry. Cancer (1990) 1.03

Screening for colorectal carcinoma in cancer family syndrome kindreds. Scand J Gastroenterol (1987) 1.01

The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. Anticancer Res (1994) 0.99

Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary nonpolyposis colorectal cancer. Mutations in brief no. 144. Online. Hum Mutat (1998) 0.98

Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. The International Collaborative Group on HNPCC. Dis Colon Rectum (1993) 0.97

Endometrial carcinoma in the cancer family syndrome. Cancer (1991) 0.97

The International Collaborative Group on HNPCC. Anticancer Res (1994) 0.96

Prognosis of colorectal cancer varies in different high-risk conditions. Ann Med (1998) 0.96

Evidence supporting exclusion of the DCC gene and a portion of chromosome 18q as the locus for susceptibility to hereditary nonpolyposis colorectal carcinoma in five kindreds. Cancer Res (1991) 0.96

No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer. Scand J Gastroenterol (2002) 0.95

Genetic polymorphisms in carcinogen metabolism and their association to hereditary nonpolyposis colon cancer. Gastroenterology (1998) 0.95

Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet (2001) 0.95

Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group. Am J Gastroenterol (1999) 0.95

Primary gastrointestinal non-Hodgkin's lymphoma. A population based study in central Finland in 1975-1993. Acta Oncol (1997) 0.94

Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group. Am J Gastroenterol (1999) 0.91

Evidence that the MCC-APC gene region in 5q21 is not the site for susceptibility to hereditary nonpolyposis colorectal carcinoma. Cancer Res (1992) 0.91

Tracing cell fates in human colorectal tumors from somatic microsatellite mutations: evidence of adenomas with stem cell architecture. Am J Pathol (1998) 0.91

The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study. Br J Cancer (1990) 0.89

Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet (2000) 0.88

The value of a follow-up programme after radical surgery for colorectal carcinoma. Scand J Gastroenterol (1989) 0.87

Screening for hereditary colorectal carcinoma. Scand J Gastroenterol (1989) 0.85

Improvements in the treatment and prognosis of colorectal carcinoma. Br J Surg (1988) 0.84

Classical Barrett esophagus contrasted with Barrett-type epithelium at normal-appearing esophagogastric junction. Central Finland Endoscopy Study Group. Scand J Gastroenterol (2000) 0.83

No evidence for dual role of loss of heterozygosity in hereditary non-polyposis colorectal cancer. Oncogene (2006) 0.83

Identification of cancer family syndrome. Gastroenterology (1986) 0.78

Biofeedback therapy in rectal prolapse patients. Dis Colon Rectum (1996) 0.78

[A breakthrough in solving the genetic background of colon cancer]. Duodecim (1993) 0.78

Serum carcinoembryonic antigen and DNA ploidy in colorectal carcinoma. A prospective study. Scand J Gastroenterol (1991) 0.78

Growth of human colorectal carcinoma implants in the mouse subrenal capsule assay. Ann Chir Gynaecol (1989) 0.77

Hereditary aspects of endometrial adenocarcinoma. Int J Cancer (1995) 0.75

Mutation analysis of SMAD2, SMAD3, and SMAD4 genes in hereditary non-polyposis colorectal. J Med Genet (2000) 0.75

[Prognosis and follow-up of colon and rectal carcinoma patients after surgical intervention]. Duodecim (1988) 0.75

The role of surgery in Crohn's disease: a retrospective analysis from a single hospital. Scand J Surg (2010) 0.75

Ischaemic colitis--a clinical study of seven patients with special emphasis on diagnostic problems. Ann Chir Gynaecol (1991) 0.75

Endo-ultrasonography for preoperative staging of rectal cancer. Ann Chir Gynaecol (1988) 0.75

Surgeons and cancer. Ann Chir Gynaecol (2000) 0.75

Screening for gastrointestinal cancers in high-risk groups. Dig Dis (1989) 0.75

[Glucose metabolism disorders following an acute alcoholic pancreatitis]. Duodecim (1998) 0.75

[Blood transfusion and prognosis of colorectal canmcer]. Duodecim (1989) 0.75

[How should patients with colorectal cancer be followed?]. Duodecim (1992) 0.75

[para-esophageal hernia--a poorly recognised form of hiatal hernia]. Duodecim (1995) 0.75

[Acetylsalicylic acid and the prevention of cancer]. Duodecim (1999) 0.75

[A familial cancer syndrome]. Duodecim (1984) 0.75